Literature DB >> 12409667

Long-term results of distal pancreatectomy for chronic pancreatitis in 90 patients.

Robert R Hutchins1, Richard S Hart, Marc Pacifico, Nicholas J Bradley, Robin C N Williamson.   

Abstract

OBJECTIVE: To determine the indications for distal pancreatectomy for chronic pancreatitis and to evaluate the risks, functional loss, and outcome of the procedure. SUMMARY BACKGROUND DATA: Chronic pancreatitis is generally associated with continued pain, parenchymal and ductal hypertension. and progressive pancreatic dysfunction, and it is a cause of premature death in patients who receive conservative treatment. Good results have recently been reported by the authors and others for resection of the pancreatic head in this disease, but distal pancreatectomy is a less popular option attended by variable success rates. It remains a logical approach for patients with predominantly left-sided pancreatic disease, however.
METHODS: A personal series of 90 patients undergoing distal pancreatectomy for chronic pancreatitis over the last 20 years has been reviewed, with a mean postoperative follow-up of 34 months (range 1-247). Pancreatic function was measured before and after operation in many patients.
RESULTS: Forty-eight of 84 patients available for follow-up had a successful outcome in terms of zero or minimal, intermittent pain. There was one perioperative death, but complications developed in 29 patients, with six early reexplorations. Morbidity was unaffected by associated splenectomy or right-to-left dissection. Late mortality rate over the follow-up period was 10%; most of these late deaths occurred because of failure to abstain from alcohol. Preoperative exocrine function was abnormal in two thirds of those tested and was unchanged at follow-up. Diabetic curves were seen in 10% of patients preoperatively, while there was an additional diabetic morbidity rate of 23% related to the procedure and late onset of diabetes (median duration 27 months) in another 23%. Diabetic onset was related to percentage parenchymal resection as well as splenectomy. Outcome was not clearly dependent on the etiology of pancreatitis or on disease characteristics as assessed by preoperative imaging. However, patients with pseudocyst disease alone did better than other groups. Twenty-one of 36 patients who failed to respond to distal pancreatectomy required further intervention, including completion pancreatectomy, neurolysis, and sphincteroplasty. Thirteen of these 21 patients achieved long-term pain relief after their second procedure.
CONCLUSIONS: Distal pancreatectomy for chronic pancreatitis from any etiology can be performed with low mortality and a good outcome in terms of pain relief and return to work in approximately 60% of patients. Little effect is seen on exocrine function of the pancreas, but there is a diabetic risk of 46% over 2 years. Pseudocyst disease is associated with the best outcome, but other manifestations of this disease, including strictures, calcification, and limited concomitant disease in the head of the pancreas, can still be associated with a good outcome.

Entities:  

Mesh:

Year:  2002        PMID: 12409667      PMCID: PMC1422619          DOI: 10.1097/00000658-200211000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  24 in total

1.  The surgical management of chronic pancreatitis: duodenum-preserving pancreatectomy.

Authors:  H G Beger; W Schlosser; M Siech; B Poch
Journal:  Adv Surg       Date:  1999

2.  Distal pancreatectomy in chronic pancreatitis.

Authors:  M H Schoenberg; W Schlosser; W Rück; H G Beger
Journal:  Dig Surg       Date:  1999       Impact factor: 2.588

3.  Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway.

Authors:  V Ablamunits; F Quintana; T Reshef; D Elias; I R Cohen
Journal:  J Autoimmun       Date:  1999-12       Impact factor: 7.094

4.  Interleukin-13 prevents autoimmune diabetes in NOD mice.

Authors:  P Zaccone; J Phillips; I Conget; R Gomis; K Haskins; A Minty; K Bendtzen; A Cooke; F Nicoletti
Journal:  Diabetes       Date:  1999-08       Impact factor: 9.461

5.  [Is a Whipple operation in chronic pancreatitis still a current procedure?].

Authors:  A Schwarz; W Schlosser; M H Schoenberg; H G Beger
Journal:  Z Gastroenterol       Date:  1999-03       Impact factor: 2.000

6.  Distal pancreatectomy: indications and outcomes in 235 patients.

Authors:  K D Lillemoe; S Kaushal; J L Cameron; T A Sohn; H A Pitt; C J Yeo
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

Review 7.  Duodenum-preserving pancreatic head resection: future standard operation in chronic pancreatitis.

Authors:  Y Kondo; H Friess; A A Tempia-Caliera; M W Büchler
Journal:  Swiss Surg       Date:  2000

8.  Value of splenic preservation during distal pancreatectomy for chronic pancreatitis.

Authors:  S Govil; C W Imrie
Journal:  Br J Surg       Date:  1999-07       Impact factor: 6.939

9.  Long-term results after surgery for chronic pancreatitis.

Authors:  G H Sakorafas; M B Farnell; D R Farley; C M Rowland; M G Sarr
Journal:  Int J Pancreatol       Date:  2000-04

10.  Surgery for chronic pancreatitis: a review of 12 years experience.

Authors:  R L Byrne; R H Gompertz; C W Venables
Journal:  Ann R Coll Surg Engl       Date:  1997-11       Impact factor: 1.891

View more
  49 in total

1.  Contemporary single-center surgical experiences in redo procedures of the pancreas: improved outcome and reduction of operative risk.

Authors:  Sabine Kersting; Monika Silvia Janot; Ansgar Michael Chromik; Dominique Suelberg; Waldemar Uhl; Matthias Hartmut Seelig
Journal:  J Gastrointest Surg       Date:  2010-11-12       Impact factor: 3.452

2.  Reoperative surgery for chronic pancreatitis: is it safe?

Authors:  Thomas Schnelldorfer; David N Lewin; David B Adams
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

3.  Distal pancreatectomy: en-bloc splenectomy vs spleen-preserving pancreatectomy.

Authors:  Laureano Fernández-Cruz; David Orduña; Gleydson Cesar-Borges; Miguel Angel López-Boado
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

Review 4.  Modified puestow lateral pancreaticojejunostomy.

Authors:  Eugene P Ceppa; Theodore N Pappas
Journal:  J Gastrointest Surg       Date:  2008-07-12       Impact factor: 3.452

Review 5.  The Surgeon's Role in Treating Chronic Pancreatitis and Incidentally Discovered Pancreatic Lesions.

Authors:  Vikrom K Dhar; Brent T Xia; Syed A Ahmad
Journal:  J Gastrointest Surg       Date:  2017-08-14       Impact factor: 3.452

6.  Cost-effectiveness of total pancreatectomy and islet cell autotransplantation for the treatment of minimal change chronic pancreatitis.

Authors:  Gregory C Wilson; Syed A Ahmad; Daniel P Schauer; Mark H Eckman; Daniel E Abbott
Journal:  J Gastrointest Surg       Date:  2014-08-06       Impact factor: 3.452

7.  Pancreatic exocrine function is preserved after distal pancreatectomy.

Authors:  James E Speicher; L William Traverso
Journal:  J Gastrointest Surg       Date:  2010-04-13       Impact factor: 3.452

8.  Proteomics identifies multipotent and low oncogenic risk stem cells of the spleen.

Authors:  Francisco Dieguez-Acuña; Shohta Kodama; Yoshiaki Okubo; Ana Cristina Paz; Steven P Gygi; Denise L Faustman
Journal:  Int J Biochem Cell Biol       Date:  2009-12-18       Impact factor: 5.085

9.  Safe closure technique for distal pancreatic resection.

Authors:  Gyula Farkas; László Leindler; Gyula Farkas
Journal:  Langenbecks Arch Surg       Date:  2004-08-28       Impact factor: 3.445

Review 10.  Chronic pancreatitis.

Authors:  Hemant M Kocher; Fieke Em Froeling
Journal:  BMJ Clin Evid       Date:  2008-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.